OncoAlert and ecancer weekly round up for August 8th - 14th, 2022
OncoAlert and ecancer weekly round up for August 8th - 14th, 2022
Topics under discussion at the WCLC 2022 presidential symposium
Atezolizumab vs best supportive care in resected NSCLC
MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC
Working to improve global cancer care access in low middle-income countries
Updates from the PROpel and MAGNITUDE studies
Update on the latest in PARP inhibitors for prostate cancer
Isatuximab + Pd in Difficult-to-Treat Patients with RRMM
ASCO Direct Highlights 2022: prostate cancer highlights
ASCO Direct Highlights 2022: lung cancer highlights
Locally and advanced immunotherapy developments and new agents in lung cancer
The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma